FIELD: chemistry.
SUBSTANCE: invention refers to compounds specified in: N-(3-carbamoyl-5,5,7,7-tetramethyl-5,7-dihydro-4H-thieno[2,3-c]pyran-2-yl)-1H-pyrazole-5-carboxamide and 2- (2-hydroxybenzamido)-5,5,7,7-tetramethyl-5,7-dihydro-4H-thieno[2,3-c]pyran-3-carboxamide.
EFFECT: treating cystic fibrosis or chronic obstructive pulmonary disease (COPD).
5 cl, 21 dwg
Title | Year | Author | Number |
---|---|---|---|
PYRIDINES SUBSTITUTED WITH HETEROARYL AND APPLICATION METHODS | 2017 |
|
RU2756743C2 |
NEW COMPOUNDS AND THEIR PHARMACEUTICAL COMPOSITIONS FOR TREATMENT OF INFLAMMATORY DISEASES | 2018 |
|
RU2785126C2 |
SUBSTITUTED CHROMANS | 2015 |
|
RU2718060C2 |
INHIBITORS OF NONPRILYZINE | 2011 |
|
RU2622288C2 |
PYRAZOLPYRIMIDINE COMPOUNDS JAK INHIBITORS AND METHODS | 2009 |
|
RU2539568C2 |
DUAL-ACTING ANTIHYPERTENSIVE COMPOUNDS, METHODS FOR PREPARING THEM, BASED PHARMACEUTICAL COMPOSITIONS AND INTERMEDIATE COMPOUNDS | 2008 |
|
RU2476427C2 |
NEW SUBSTITUTED BIARYL COMPOUNDS AS INDOLAMINE-2,3-DIOXYGENASE (IDO) INHIBITORS | 2018 |
|
RU2786586C2 |
AMIDES OF QUINOLINE AND QUINAZOLINE, USEFUL AS A SODIUM CHANNEL MODULATORS | 2014 |
|
RU2683788C2 |
4-AMINOQUINAZOLINE ANTAGONISTS OF SELECTIVE SODIUM AND CALCIUM ION CHANNELS | 2004 |
|
RU2378260C2 |
COMPOUNDS AND COMPOSITIONS FOR IRE1 INHIBITION | 2018 |
|
RU2795572C2 |
Authors
Dates
2019-12-11—Published
2014-08-05—Filed